miles ahead bioconsulting proposition

MILES AHEAD BioConsulting, LLC [email protected] 339-223-9287 With skyrocketing drug development costs, uncertain regulatory approvals, intense price and market forces along with earlier generic challenges, today’s biopharmaceutical business model is under more pressure than ever. In short, drug development and commercialization is an expensive and risky enterprise with shortening product life- cycles. Furthermore, health care policy and potentially disruptive medical technology are rapidly evolving, while significant product investments can take years (typically three to five) to bear fruit. Taken together, today’s commercial product developer is asked to hit moving strategic targets well into an uncertain future. Posed with this challenge, a flexible commercial strategy along all stages of the life- cycle continuum is paramount in managing risk while developing a most compelling and sustainable value proposition. MILES AHEAD BioConsulting, LLC and Stuart A. Murray, M.S., bring over 25 years of broad based expertise as a proven commercial strategist and product developer. He’s led global cross- functional development teams, Marketing and Program Management departments, devised and executed brand strategies & optimized life-cycle value for products in the acute care space, including the blockbuster CUBICIN ® , AmBisome ® and SIVEXTRO ® . His experience is augmented by a customer-centric understanding gained as a sales representative early in his career. Importantly, Murray is also a student of healthcare policy reform, constantly analyzing developments, identifying trends and projecting how the ACA will shape future drug utilization patterns. Offering a unique blend and range of consulting services within an integrated view of the healthcare arena to optimally strategize, plan and commercialize acute care assets. Consulting services include, but are not limited to: Pre-Commercial Product Planning o Identifying and assessing scientific, clinical and business attributes for sustainable differentiation o Market research to support validated target product profile o Health economics, pricing and value proposition strategy o Commercial operations planning, including marketing, decision support and sales functions Commercialization o Healthcare provider and care setting segmentation strategy o Positioning and messaging to ensure sustainable differentiation o Strategic commercial resource allocation and communication planning o Current and future competitor assessments, including generics Life-Cycle Value Optimization

Upload: stuart-murray

Post on 13-Apr-2017

83 views

Category:

Documents

1 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: Miles Ahead BioConsulting Proposition

MILES AHEAD BioConsulting, [email protected]

339-223-9287

With skyrocketing drug development costs, uncertain regulatory approvals, intense price and market forces along with earlier generic challenges, today’s biopharmaceutical business model is under more pressure than ever. In short, drug development and commercialization is an expensive and risky enterprise with shortening product life-cycles.

Furthermore, health care policy and potentially disruptive medical technology are rapidly evolving, while significant product investments can take years (typically three to five) to bear fruit. Taken together, today’s commercial product developer is asked to hit moving strategic targets well into an uncertain future.

Posed with this challenge, a flexible commercial strategy along all stages of the life-cycle continuum is paramount in managing risk while developing a most compelling and sustainable value proposition.

MILES AHEAD BioConsulting, LLC and Stuart A. Murray, M.S., bring over 25 years of broad based expertise as a proven commercial strategist and product developer. He’s led global cross-functional development teams, Marketing and Program Management departments, devised and executed brand strategies & optimized life-cycle value for products in the acute care space, including the blockbuster CUBICIN®, AmBisome® and SIVEXTRO®. His experience is augmented by a customer-centric understanding gained as a sales representative early in his career. Importantly, Murray is also a student of healthcare policy reform, constantly analyzing developments, identifying trends and projecting how the ACA will shape future drug utilization patterns.

Offering a unique blend and range of consulting services within an integrated view of the healthcare arena to optimally strategize, plan and commercialize acute care assets. Consulting services include, but are not limited to:

Pre-Commercial Product Planning o Identifying and assessing scientific, clinical and business attributes for sustainable

differentiationo Market research to support validated target product profileo Health economics, pricing and value proposition strategyo Commercial operations planning, including marketing, decision support and sales

functions Commercialization

o Healthcare provider and care setting segmentation strategyo Positioning and messaging to ensure sustainable differentiationo Strategic commercial resource allocation and communication planningo Current and future competitor assessments, including generics

Life-Cycle Value Optimizationo Product improvements (formulations, presentations, delivery systems, etc.)o Scientific development (indications, phase IV studies, IIS programs, registries, health

economics, etc.)o Market exclusivity extension strategies

MILES AHEAD is a 1957 jazz album by Miles Davis, the foremost innovator and visionary in Jazz History

mailto:[email protected]